Nanoluciferase-based complementation assay for systematic profiling of GPCR-GRK interactions

Methods Cell Biol. 2022:169:309-321. doi: 10.1016/bs.mcb.2022.04.001. Epub 2022 May 4.

Abstract

G protein-coupled receptor kinases (GRKs) are a family of seven soluble receptor-modifying enzymes which are essential regulators of GPCR activity. Following agonist-induced receptor activation and G protein dissociation, GRKs prime the receptor for desensitization through phosphorylation of its C terminus, which subsequently allows arrestins to bind and initiate the receptor internalization process. While GRKs constitute key GPCR-interacting proteins, to date, no method has been put forward to readily and systematically determine the preference of a specific GPCR towards the seven different GRKs (GRK1-7). This chapter describes a simple and standardized approach for systematic profiling of GRK1-7-GPCR interactions relying on the complementation of the split Nanoluciferase (NanoBiT). When applied to a set of GPCRs (MOR, 5-HT1A, B2AR, CXCR3, AVPR2, CGRPR), including two intrinsically β-arrestin-biased receptors (ACKR2 and ACKR3), this methodology yields highly reproducible results highlighting different GRK recruitment profiles. Using this assay, further characterization of MOR, a crucial target in the development of analgesics, reveals not only its GRK fingerprint but also related kinetics and activity of various ligands for a single GRK.

Keywords: ACKR3; Arrestin; B2AR; GRK2; GRK3; GRK5; GRK6; Kinase; MOR; NanoBiT; opioids.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arrestins / metabolism
  • G-Protein-Coupled Receptor Kinases* / metabolism
  • Receptors, G-Protein-Coupled* / metabolism
  • Signal Transduction / physiology
  • beta-Arrestins / metabolism

Substances

  • Arrestins
  • Receptors, G-Protein-Coupled
  • beta-Arrestins
  • G-Protein-Coupled Receptor Kinases